News

News

 

 

Inside the Dolomite Labs: Polyacrylamide bead formation using FluoSurf

23rd May 2019

In anticipation of the new product launch of FluoSurf, our new fluorinated emulsion stabilizer, the Dolomite Team have been testing the product across a range of applications. This week, we have been synthesizing polyacrylamide beads.

Read more

Inside the Dolomite Labs: Polyacrylamide bead formation using FluoSurf

Dolomite Microfluidics partners with Emulseo to improve droplet production

21st May 2019

Dolomite Microfluidics is pleased to announce a new partnership with Emulseo – a start-up company dedicated to the design and production of high quality surfactants for droplet-based microfluidics – to distribute FluoSurf, a high performance continuous phase specifically formulated to stabilize aqueous droplets in microfluidic systems.

Read more

Dolomite Microfluidics partners with Emulseo to improve droplet production

Dolomite presents high-throughput systems for cell encapsulation

13th March 2019

Dolomite Microfluidics is delighted to share news about the arrival of a novel microencapsulation systems. µEncapsulator Systems have been specifically designed to meet the needs of research biologists. The user-friendly, high-throughput systems offer simple, straightforward encapsulation of cells, bacteria, microbiome, and/or functionalised beads in high precision, identically-sized picolitre droplets.

Read more

Dolomite presents high-throughput systems for cell encapsulation

Fluorescent biosensors as tools for drug therapeutics

13th February 2019

Read about how researchers in the School of Pharmacy at the University of Nottingham have been using Dolomite Microfluidic’s chips to enhance their work on drug encapsulation and therapeutic delivery.

Read more

Fluorescent biosensors as tools for drug therapeutics

Making liposomal formulations for the delivery of RNA vaccines

24th January 2019

A Dolomite Microfluidics’ set-up for high throughput cell encapsulation is helping researchers at the Department of Medicine at Imperial College, London, to develop novel liposomal formulations for RNA vaccines targeting diseases such as HIV, influenza, rabies and chlamydia.

Read more

Making liposomal formulations for the delivery of RNA vaccines